Assay Development, DNA, Therapies and Workshop

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Assay Development

DNA

Therapies

Workshop

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

Agency IQ

JULY 21, 2023

The next chapter in the ctDNA story: Still promising, not ready for prime time A recent workshop summed up the state of play for circulating tumor DNA. subsequent superior/inferior supportive care, lifestyle changes, and/or use of additional therapies). years before they would have been available otherwise.

FDA

FDA Clinical Trials Treatment DNA

Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update

Agency IQ

FEBRUARY 2, 2024

Additionally, the plan aims to improve the quality of life for the over 12 million cancer survivors who benefited from earlier detection, effective therapies and supportive care. See AgencyIQs analysis of a workshop on novel methodology qualification.] Even under the shadow of the Covid-19 pandemic, 1.2

Clinical Trials

Clinical Trials Trials Treatment Production

Drug Discovery Digest

Article FDA Thank You The next chapter in the ctDNA story: Still promising, not ready for prime time

Article EMA Thank You EMA finalizes clinical anticancer therapeutic guidance update

Stay Connected